Baijiayun Group (RTC) shares were up 66% in recent Thursday premarket activity, after it said overnight it partnered with Beijing Xinlantian Education Technology to create artificial intelligence-driven rehabilitation programs for children with autism.
UniQure (QURE) stock jumped more than 49% after saying its experimental gene therapy, AMT-130, received breakthrough therapy designation from the US Food and Drug Administration to treat Huntington's disease.
Eli Lilly (LLY) shares rose 13%, after the drug manufacturer said its drug orforglipron met primary and secondary endpoints compared with a placebo in a phase 3 trial evaluating its safety and efficacy in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.
Kosmos Energy (KOS) stock was 7.2% higher after the company and BP (BP) said that the first cargo of liquefied natural gas from the Greater Tortue Ahmeyim project, offshore Mauritania and Senegal, has been loaded.
Charles Schwab (SCHW) shares advanced over 4% after it posted higher Q1 adjusted earnings and net revenue from a year earlier.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。